Psychiatry and Neurology, Neurology · Oroville, CA
NPI
1295786507
Since 2006
Specialty
Psychiatry and Neurology, Neurology
Code 2084N0400X
Group practices
2
Medicare group memberships
Hospitals
2
Hospital affiliations
2767 Olive Hwy
Oroville, CA, 95966
Phone (530) 538-3170
Groups this clinician bills Medicare through
Medicare paid, 2024
$18K
326 services
Medicare patients, 2024
227
Average age 70
Drug cost, 2024
$761K
2,731 prescriptions
Company payments, 2025
$1,155
From 13 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by John G Schmidt was code 95819 (neurologic), 161 times for 151 patients. In total John G Schmidt billed 326 services in 12 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-06.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 95819 Neurologic | Facility | 161 | 151 | $38.03 | $6,123 |
| 99222 Hospital E&M - Initial | Facility | 56 | 52 | $98.80 | $5,533 |
| 95719 Neurologic | Facility | 52 | 49 | $66.32 | $3,449 |
| 99221 Hospital E&M - Initial | Facility | 38 | 37 | $58.91 | $2,238 |
By year: 2022 $44K for 639 services; 2023 $20K for 360 services; 2024 $18K for 326 services.
Medicare prescription drug claims, 2024
In 2024, the drug John G Schmidt prescribed most often to Medicare patients was Topiramate, with 288 prescriptions and refills. In total John G Schmidt wrote 2,731 Medicare prescriptions that cost $761K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Topiramate Generic | 288 | 427 | 51 | $3,778 |
| Levetiracetam Generic | 239 | 449 | 54 | $13K |
| Lacosamide Generic | 217 | 231 | 34 | $34K |
| Carbidopa-Levodopa Carbidopa/Levodopa | 203 | 379 | 48 | $4,300 |
| Amantadine Amantadine Hcl | 148 | 199 | 26 | $9,418 |
| Primidone Generic | 118 | 196 | 29 | $3,148 |
| Lamotrigine Generic | 106 | 126 | 15 | $1,568 |
| Cyclobenzaprine Hcl Generic | 106 | 134 | 29 | $790 |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 93 | 185 | 27 | $6,788 |
| Oxcarbazepine Generic | 81 | 129 | 20 | $4,965 |
| Gabapentin Generic | 76 | 96 | 17 | $1,123 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 73 | 107 | 15 | $1,237 |
| Ropinirole Hcl Generic | 55 | 98 | 14 | $1,463 |
| Pregabalin Generic | 49 | 56 | 11 | $1,808 |
| Duloxetine Hcl Generic | 46 | 52 | Under 11 | $746 |
Brand drugs: - claims; generic drugs: 2,526 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid John G Schmidt $1,155 ($1,155 in general payments such as food, travel and fees) from 13 companies. The largest payer was Abbvie Inc. with $307.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 20 | $307 |
| Pfizer Inc. PFE | 8 | $275 |
| SK Life Science, Inc. | 6 | $127 |
| Neurocrine BioSciences, Inc. NBIX | 3 | $91.65 |
| UCB, Inc. UCB.BR | 3 | $70.63 |
| Janssen Biotech, Inc. JNJ | 3 | $59.53 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $47.69 |
| Aucta Pharmaceuticals, Inc. | 2 | $39.65 |
| MDD US Operations, LLC | 2 | $34.07 |
| Amneal Pharmaceuticals LLC AMRX | 2 | $31.15 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.